UBS Group’s Principal Contrarian Value Index ETF PVAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-1,611
Closed -$37K – 8784
2020
Q2
$37K Sell
1,611
-315
-16% -$6.8K ﹤0.01% 6130
2020
Q1
$37K Buy
1,926
+1,916
+19,160% +$47.3K ﹤0.01% 6074
2019
Q4
$0 Sell
10
-146
-94% -$4.02K ﹤0.01% 8631
2019
Q3
$4K Buy
+156
New +$4.08K ﹤0.01% 7595
2019
Q2
– Sell
-1
Closed – – 8362
2019
Q1
$0 Hold
1
– – ﹤0.01% 8433
2018
Q4
$0 Buy
+1
New +$26 ﹤0.01% 8487
2018
Q3
– Sell
-29
Closed -$1K – 8429
2018
Q2
$1K Buy
29
+4
+16% +$104 ﹤0.01% 7880
2018
Q1
$1K Buy
+25
New +$655 ﹤0.01% 7706

UBS Group's PVAL Position: Q3 2020 in Review

UBS Group sold out of Principal Contrarian Value Index ETF (PVAL) in Q3 2020, closing a stake of 1,611 shares — an estimated $37K sold.

UBS Group first reported a position in PVAL in Q1 2018 and held it in 8 quarters. The position peaked at $37K in Q2 2020. 0 funds tracked by Wall St. Rank hold PVAL as of Q3 2020.

  • UBS Group reported no remaining Principal Contrarian Value Index ETF position as of Q3 2020 after selling out during the quarter.
  • UBS Group sold 1,611 Principal Contrarian Value Index ETF shares in Q3 2020, an estimated $37K.
  • UBS Group first reported a position in Principal Contrarian Value Index ETF in Q1 2018 and held it in 8 quarters.
  • UBS Group's Principal Contrarian Value Index ETF position peaked at $37K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Principal Contrarian Value Index ETF as of Q3 2020.

Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.